{
  "meta": {
    "title": "52_Pharmacology_Neet_2020",
    "url": "https://brainandscalpel.vercel.app/52-pharmacology-neet-2020-1098edfe.html",
    "scrapedAt": "2025-11-30T12:58:05.638Z"
  },
  "questions": [
    {
      "text": "Which of the following is an inhibitor of DNA synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "6-mercaptopurine"
        },
        {
          "id": 2,
          "text": "Mitomycin"
        },
        {
          "id": 3,
          "text": "Actinomycin"
        },
        {
          "id": 4,
          "text": "Asparaginase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>6-Mercaptopurine</strong> is an inhibitor of DNA synthesis.</p>\n<p>6-Mercaptopurine is inactive in its parent form. It must be metabolized by hypoxanthine-guanine&nbsp;phosphoribosyltransferase to form <strong>monophosphate nucleotide 6-thioinosinic acid.</strong> This inhibits several enzymes of de novo purine nucleotide synthesis.</p>\n<p>Option B- <strong>Mitomycin</strong> acts as an <strong>alkylating agent</strong> and crosslinks DNA. It also generates free radicals which damage DNA.</p>\n<p>Option C-<strong> Actinomycin</strong> causes <strong>single-strand breaks in DNA</strong>. It&nbsp;blocks RNA transcription as well.</p>\n<p>Option D-<strong> L-Asparaginase</strong>&nbsp;causes the breakdown of asparagine and thus <strong>interferes with protein synthesis.</strong></p><hr><h3>Related Pearl: Enzymes of Purine Synthesis Pathway and Their Regulators</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p><strong>Regulators</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP Glutamyl Amidotransferase</p>\n</td>\n<td>\n<p>Inhibited by Amp &amp; GMP</p>\n<p>Activator &nbsp;PRPP</p>\n<p>Activated by Glutamine</p>\n<p>Diazanorleucine(inhibitor)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP synthetase</p>\n</td>\n<td>\n<p>Activator pi</p>\n<p>Inhibitors &nbsp;purine ribonucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Formyltransferase</p>\n</td>\n<td>\n<p>Methotrexate, Anti-folate drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VI Synthetase</p>\n</td>\n<td>\n<p>Azaserine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenylosuccinase ,IMP Dehydrogenase</p>\n</td>\n<td>\n<p>6-mercaptopurine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IMP Dehydrogenase</p>\n</td>\n<td>\n<p>mycophenolic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0782",
      "difficulty": "easy"
    },
    {
      "text": "A patient on lithium therapy developed hypertension. He was started on thiazides for hypertension. After few days, he developed coarse tremors and other symptoms suggestive of lithium toxicity. Explain the likely mechanism of this interaction.",
      "choices": [
        {
          "id": 1,
          "text": "Thiazide inhibits the metabolism of lithium"
        },
        {
          "id": 2,
          "text": "Thiazides act as an add on drug to lithium"
        },
        {
          "id": 3,
          "text": "Thiazides increase the tubular reabsorption of lithium"
        },
        {
          "id": 4,
          "text": "Thiazides cause water loss therby increase lithium levels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Thiazides </strong>act by<strong> increasing</strong> the<strong> tubular reabsorption of lithium.</strong></p>\n<p>Thiazide use is accompanied by <strong>sodium loss</strong> which is <strong>compensated</strong> in a few days by increased <strong>reabsorption of Na<sup>+</sup></strong> in the proximal tubule.</p>\n<p>The kidney handles both lithium and Na<sup>+ </sup>in the same way. Thus, along with Na<sup>+ </sup>reabsorption, there will be an increase in the <strong>reabsorption of lithium</strong> also, resulting in decreased excretion of lithium.</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0775",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following should not be prescribed with theophylline?",
      "choices": [
        {
          "id": 1,
          "text": "Erythromycin"
        },
        {
          "id": 2,
          "text": "Cefotaxime"
        },
        {
          "id": 3,
          "text": "Cotrimoxazole"
        },
        {
          "id": 4,
          "text": "Amoxicillin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Erythromycin</strong>&nbsp;should not be prescribed with theophylline.</p>\n<p>Theophylline is mainly metabolized by CYP1A2 in the liver.&nbsp;Erythromycin <strong>inhibits CYP1A2</strong> and thereby <strong>decreases</strong> the <strong>clearance</strong> of<strong> theophylline</strong>.</p>\n<p>Factors decreasing the clearance of theophylline are:</p>\n<ul>\n<li>Drugs - erythromycin, cimetidine, ciprofloxacin,&nbsp;allopurinol, fluvoxamine, zileuton, zafirlukast</li>\n<li>Congestive heart failure</li>\n<li>Liver disease</li>\n<li>Pneumonia</li>\n<li>Viral infection and vaccination</li>\n<li>High-carbohydrate diet</li>\n<li>Old age</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0804",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs gets deposited in cornea?",
      "choices": [
        {
          "id": 1,
          "text": "Leflunamide"
        },
        {
          "id": 2,
          "text": "Chloroquine"
        },
        {
          "id": 3,
          "text": "Methotrexate"
        },
        {
          "id": 4,
          "text": "Sulfasalazine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Chloroquine</strong>, an anti-malarial drug may get deposited in the cornea leading to corneal opacity.</p>\n<p>Ocular toxicity of chloroquine:</p>\n<ul>\n<li>Short-term therapy -<strong>&nbsp;blurring of vision</strong> and <strong>diplopia,</strong>&nbsp;reversible&nbsp;on stoppage of drug.</li>\n<li>Long-term use (high-dose):&nbsp;\n<ul>\n<li>Keratopathy</li>\n<li>Pigmentary retinopathy</li>\n<li>Optic atrophy</li>\n</ul>\n</li>\n</ul>\n<p><strong>Hydroxychloroquine</strong> has lower ocular toxicity compared to chloroquine.&nbsp;</p>\n<p><strong>Drugs&nbsp;</strong>causing corneal opacity:</p>\n<ul>\n<li>Amiodarone</li>\n<li>Phenothiazine</li>\n<li>Indomethacin</li>\n<li>Chloroquine</li>\n</ul>\n<p>Long-term treatment with these drugs can cause a whorl-like opacity in the corneal epithelium called <strong>cornea verticillata.</strong> It is also seen in <strong>Fabry's disease.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0612",
      "difficulty": "easy"
    },
    {
      "text": "A patient was prescribed an antipsychotic drug following which he developed parkinsonism. Which of the following drugs​ can be given?",
      "choices": [
        {
          "id": 1,
          "text": "Trihexiphenidyl"
        },
        {
          "id": 2,
          "text": "Entacapone"
        },
        {
          "id": 3,
          "text": "Rasagiline"
        },
        {
          "id": 4,
          "text": "Pramipexole"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Trihexyphenidyl </strong>is the drug of choice for <strong>drug-induced parkinsonism</strong>. It is a <strong>central anticholinergic.</strong></p>\n<p>Drug-induced parkinsonism is a condition caused by certain drugs having D2 antagonistic action (typical antipsychotics).&nbsp;The decrease in dopaminergic activity results in an unbalanced cholinergic activity. Anticholinergics act by restoring the balance.</p><hr><h3>Related Pearl: Extrapyramidal side effects of antipsychotic drugs</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Adverse reactions</strong></span></div>\n</td>\n<td>\n<div><span><strong>Time of onset</strong></span></div>\n</td>\n<td>\n<div><span><strong>Features</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Acute dystonia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>1 to 5 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Spasm of muscles of tongue, face, neck, back</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Diphenhydramine or benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Akathisia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 60 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Restlessness</span></div>\n</td>\n<td>\n<div><span><strong>Propranolol</strong>,<strong>&nbsp;</strong>lorazepam, diphenhydramine, benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Parkinsonism</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 30 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Bradykinesia, rigidity, tremors</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Dose reduction, change medication, antiparkinsonian agents</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Tardive dyskinesia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Months to years</span></div>\n</td>\n<td>\n<div class=\"p1\">\n<div class=\"p1\"><span>Orofacial dyskinesia (may be reversible with early recognition and drug discontinuation)</span></div>\n</div>\n</td>\n<td>\n<div class=\"p1\"><span>VMAT-2 inhibitors <strong>valbenazine</strong> and <strong>deutetrabenazine</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Weeks to months</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Extreme rigidity, fever, unstable blood pressure</span></div>\n</td>\n<td>\n<div class=\"p1\"><span><strong>Dantrolene</strong></span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0779",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following antiarrhythmic drugs is contraindicated in a patient with interstitial lung disease?",
      "choices": [
        {
          "id": 1,
          "text": "Amiodarone"
        },
        {
          "id": 2,
          "text": "Sotalol"
        },
        {
          "id": 3,
          "text": "Quinidine"
        },
        {
          "id": 4,
          "text": "Lignocaine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Amiodarone</strong> is&nbsp;<strong>contraindicated</strong> in a patient with <strong>interstitial lung disease.</strong></p>\n<p>The most serious<strong> adverse effect</strong> during chronic amiodarone therapy is <strong>pulmonary fibrosis</strong>, which can be rapidly progressive and fatal. <strong>Underlying lung disease</strong>, doses of 400 mg/day or more, and recent pulmonary insults such as pneumonia appear to be <strong>risk factors</strong> for this condition.</p>\n<p>Amiodarone is a class III antiarrhythmic drug.</p>\n<p>The side effects of amiodarone include:</p>\n<ul>\n<li>Pulmonary fibrosis</li>\n<li>Hypotension, depressed ventricular function</li>\n<li>Torsades de pointes</li>\n<li>Corneal microdeposits</li>\n<li>Hepatotoxicity</li>\n<li>Neuropathies</li>\n<li>Photosensitivity</li>\n<li>Thyroid dysfunction</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0777",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs acts by inhibiting the late sodium current in the heart?",
      "choices": [
        {
          "id": 1,
          "text": "Ivabradine"
        },
        {
          "id": 2,
          "text": "Ranolazine"
        },
        {
          "id": 3,
          "text": "Trimetazidine"
        },
        {
          "id": 4,
          "text": "Fasudil"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ranolazine</strong> acts by inhibiting the <strong>late sodium current</strong> in the heart.</p>\n<p>Late sodium current (I<sub>Na</sub>) facilitates entry of calcium via the sodium-calcium exchanger. <strong>Inhibition</strong> of&nbsp;<strong>I<sub>Na</sub>,</strong> therefore, reduces the intracellular calcium concentration which in turn reduces the diastolic tension, cardiac contractility and work.</p>\n<p>At higher doses, it may also modify the fatty acid oxidation, which improves the efficiency of cardiac oxygen utilization.</p>\n<p>It is used in the prophylaxis of <strong>angina.</strong></p><hr><h3>Related Pearl: Anti-anginal drugs</h3><p>Anti-anginal drugs can be divided into the following categories:</p>\n<ul>\n<li><strong>Nitrates</strong> - dilates veins &gt; arteries, reduces preload</li>\n<li><strong>Calcium channel blockers</strong> - blocks L-type calcium channels\n<ul>\n<li>Dihydropyridines - amlodipine, nifedipine</li>\n<li>Non-dihydropyridines - verapamil, diltiazem</li>\n</ul>\n</li>\n<li><strong>Beta-blockers</strong> - decreases heart rate, contractility and oxygen demand</li>\n<li>Other drugs:&nbsp;\n<ul>\n<li><strong>Ranolazine</strong> - late Na<sup>+</sup>&nbsp;channel blocker</li>\n<li><strong>Ivabradine</strong> - inhibit funny currents in SA node</li>\n<li><strong>Nicorandil</strong> - K<sup>+</sup>-ATP channel agonist</li>\n<li><strong>Trimetazidine</strong> - pFOX inhibitor</li>\n<li><strong>Fasudil</strong> - rho-kinase inhibitor</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0616",
      "difficulty": "medium"
    },
    {
      "text": "A patient with diabetes and COPD developed post-operative urinary retention. Which of the following drugs can be used for short-term treatment of the condition?",
      "choices": [
        {
          "id": 1,
          "text": "Tamsulosin"
        },
        {
          "id": 2,
          "text": "Bethanechol"
        },
        {
          "id": 3,
          "text": "Terazosin"
        },
        {
          "id": 4,
          "text": "Methacoline"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tamsulosin</strong> is the drug used to relieve the symptoms in cases of postoperative<strong> urinary retention </strong>in a patient with<strong> COPD.</strong></p>\n<p>It is also efficacious in the treatment of benign prostatic hyperplasia (BPH)&nbsp;with little effect on blood pressure.&nbsp;</p>\n<p>Option B:&nbsp;<strong>Bethanechol</strong> is the drug of choice to relieve the symptoms in cases of postoperative urinary retention. However, it&nbsp;can cause <strong>bronchoconstriction</strong> in patients with COPD. Hence tamsulosin is the best answer here.</p>\n<p>Option C:<strong>&nbsp;Terazosin</strong>&nbsp;is an &alpha;<sub>1</sub> receptor antagonist, used in the treatment of <strong>benign</strong> <strong>prostatic</strong> <strong>hyperplasia</strong> (BPH).&nbsp;</p>\n<p>Option D:&nbsp;<strong>Methacholine&nbsp;</strong>is a muscarinic agonist but acts specifically on <strong>bronchial</strong> <strong>smooth</strong> <strong>muscle</strong> causing its contraction. It is available as an inhalational agent and is used for the diagnosis of bronchial hyper-reactivity in patients who do not have clinically apparent asthma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0776",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is used for the treatment of motion sickness?",
      "choices": [
        {
          "id": 1,
          "text": "Cetrizine"
        },
        {
          "id": 2,
          "text": "Promethazine"
        },
        {
          "id": 3,
          "text": "Misolastin"
        },
        {
          "id": 4,
          "text": "Loratidine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Promethazine</strong> is used for <strong>motion sickness. </strong>It&nbsp;is an antihistaminic agent that acts as an antagonist of H<sub>1</sub> receptors. It also has <strong>central anticholinergic </strong>activity that is responsible for its <strong>antiemetic action.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0784",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a prokinetic?",
      "choices": [
        {
          "id": 1,
          "text": "5HT4 agonist"
        },
        {
          "id": 2,
          "text": "Dopamine antagonist"
        },
        {
          "id": 3,
          "text": "Motilin"
        },
        {
          "id": 4,
          "text": "Diphenylmethane"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Diphenylmethane</strong> is not a prokinetic agent. Its derivative (Bisacodyl) is used as a <strong>laxative.</strong></p>\n<p><strong>Prokinetic</strong> agents<strong>&nbsp;</strong>are the drugs that <strong>increase GI motility</strong> and transit of material in the GI tract. These&nbsp;agents include:</p>\n<ul>\n<li>Dopamine receptor antagonists- <strong>metoclopramide</strong> and <strong>domperidone</strong></li>\n<li>Serotonin receptor agonists- <strong>cisapride</strong> and prucalopride</li>\n<li><strong>Motilin</strong></li>\n<li>Macrolide antibiotics mimicking motilin - erythromycin</li>\n<li>Miscellaneous agents:\n<ul>\n<li>Sincalide (C-terminal octapeptide of CCK)</li>\n<li>Camicinal (motilin receptor agonist)</li>\n<li>Relamorelin&nbsp;(ghrelin receptor agonist)</li>\n<li>Velusetrag and naronapride (5HT<sub>4&nbsp;</sub>agonists)</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0613",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is used in the first-line management of postmenopausal osteoporosis?",
      "choices": [
        {
          "id": 1,
          "text": "Estrogen"
        },
        {
          "id": 2,
          "text": "Bisphosphonates"
        },
        {
          "id": 3,
          "text": "Raloxifene"
        },
        {
          "id": 4,
          "text": "Combined oral contraceptives"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Bisphosphonates</strong> are used&nbsp;in the first-line management of <strong>postmenopausal osteoporosis.</strong></p>\n<p>Bisphosphonates are analogs of pyrophosphates. They specifically <strong>inhibit bone resorption</strong> and thus are very effective for the treatment of postmenopausal osteoporosis.</p>\n<p>Bisphosphonates concentrate at sites of active remodeling. They remain in the matrix until the bone is remodeled. Then, they are released in the acid environment of the resorption lacunae and induce apoptosis in osteoclasts.</p>\n<p>Classification of bisphosphonates (mainly based on potency):</p>\n<div class=\"panel-body ng-scope\">\n<p class=\"ng-binding ng-scope\">First-generation:</p>\n<ul>\n<li>Etidronate (least potent)</li>\n<li>Clodronate</li>\n<li>Tiludronate</li>\n</ul>\n<p>Second-generation: 10-100 times more potent than the first generation &nbsp;</p>\n<ul>\n<li>Alendronate</li>\n<li>Pamidronate</li>\n<li>Ibadronate</li>\n</ul>\n<p>Third-generation: 10,000 times more potent than the first generation &nbsp;</p>\n<ul>\n<li>Risedronate</li>\n<li>Zoledronate</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0781",
      "difficulty": "easy"
    },
    {
      "text": "What is the mechanism of resistance by lactamases​ to β-lactam antibiotics?",
      "choices": [
        {
          "id": 1,
          "text": "Alteration of penicillin binding protein"
        },
        {
          "id": 2,
          "text": "Degradation of  antibiotics"
        },
        {
          "id": 3,
          "text": "Drug efflux"
        },
        {
          "id": 4,
          "text": "Alteration in 50s ribosome structure"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Resistance</strong> by <strong>lactamases</strong> is through the <strong>degradation of antibiotics.</strong></p>\n<div class=\"page\" title=\"Page 1166\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The bacterial cell wall is made of heteropolymeric <strong>peptidoglycan</strong> that confers mechanical stability. The &beta;-lactam antibiotics <strong>inhibit</strong> the last step in peptidoglycan synthesis by acylating the <strong>transpeptidase</strong> via cleavage of the &ndash;CO&ndash;N&ndash; bond of the &beta;-lactam ring. These transpeptidase <strong>targets</strong> are collectively called <strong>Penicillin Binding Proteins</strong> (PBPs)</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Beta-lactamases</strong> are enzymes produced by certain bacteria that inactivates&nbsp;&beta;-lactam antibiotics by <strong>hydrolysis</strong> of the &beta;-lactam ring in their structure.</p>\n<p>The <strong>resistance</strong> to <strong>penicillins</strong> and other beta-lactam antibiotics can be conferred through one of the four mechanisms:</p>\n<ol>\n<li>Inactivation of antibiotic by lactamases</li>\n<li>Modification of target PBPs</li>\n<li>Impaired penetration of drug to target PBPs</li>\n<li>Antibiotic efflux</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0778",
      "difficulty": "hard"
    },
    {
      "text": "A female patient is on first-line pharmacological therapy for bipolar disorder for 6 months. She is fasting for a few days due to religious reasons and presented with seizures, coarse tremors, confusion, and weakness of limbs. Which of the following investigations should be done to help diagnose her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Serum potassium level"
        },
        {
          "id": 2,
          "text": "Serum lithium level"
        },
        {
          "id": 3,
          "text": "ECG"
        },
        {
          "id": 4,
          "text": "MRI"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features given in the question are most likely suggestive of <strong>lithium</strong> <strong>toxicity</strong>, and hence <strong>serum lithium levels</strong> should be measured to confirm it.</p>\n<p><strong>Lithium</strong>&nbsp;is a <strong>mood stabilizer</strong> with a very narrow therapeutic index and is the <strong>first line</strong> of management in <strong>bipolar disorder</strong>.</p>\n<p>The kidney handles both <strong>lithium</strong> and&nbsp;<strong>Na</strong><sup><strong>+</strong>&nbsp;</sup>in the same way via <strong>ENac channel</strong>. Thus during <strong>fasting/dehydration</strong>, along with&nbsp;<strong>Na<sup>+&nbsp;</sup>reabsorption</strong> in renal tubules, there will be an&nbsp;increase in the&nbsp;<strong>reabsorption of&nbsp;lithium&nbsp;</strong>leading to lithium toxicity.</p>\n<p>Lithium has a very narrow therapeutic index of&nbsp;<strong>0.8-1.2 mEq/L.</strong>&nbsp;The severity of lithium toxicity is often divided into the following three grades:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade</strong></td>\n<td>\n<p><strong>Sr. lithium concentration </strong>(in mEq/L)</p>\n</td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td><strong>Mild symptoms</strong></td>\n<td><strong>1.5-2.5&nbsp;</strong></td>\n<td>nausea, vomiting, <strong>tremor</strong>, and fatigue</td>\n</tr>\n<tr>\n<td><strong>Moderate intoxication</strong></td>\n<td><strong>2.5-3.5&nbsp;</strong></td>\n<td><strong>confusion</strong>, agitation, delirium, tachycardia, and hypertonia</td>\n</tr>\n<tr>\n<td><strong>Severe intoxication</strong></td>\n<td><strong>&gt;3.5&nbsp;</strong></td>\n<td>coma, <strong>seizures</strong>, hyperthermia, and hypotension</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A fine tremor is common in patients taking lithium at therapeutic doses.&nbsp;Therapeutic lithium tremor is generally symmetric, limited to the arms, and nonprogressive. The tremor from <strong>lithium toxicity</strong> is&nbsp;<strong>coarser</strong>&nbsp;and&nbsp;<strong>more disabling</strong>, may also affect the legs, and occurs with other symptoms of toxicity.&nbsp;Other adverse effects include&nbsp;mental confusion, <strong>hypothyroidism</strong>, <strong>nephrogenic</strong>&nbsp;<strong>diabetes insipidus,</strong>&nbsp;and&nbsp;edema.</p>\n<p>As lithium is readily dialyzed, lithium overdose or toxicity is treated with <strong>hemodialysis</strong>.</p>\n<p>*Note - Serum&nbsp;<strong>Na</strong><sup><strong>+</strong>&nbsp;</sup>levels are significant with respect to&nbsp;<strong>lithium toxicity</strong>, where as serum potassium levels becomes significant in <strong>digoxin toxicity</strong>.&nbsp;<strong>Hypokalemia </strong>increases&nbsp;the&nbsp;risk&nbsp;of digoxin&nbsp;toxicity.</p><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0611",
      "difficulty": "easy"
    },
    {
      "text": "Pegloticase is used in management of:",
      "choices": [
        {
          "id": 1,
          "text": "Chronic gout"
        },
        {
          "id": 2,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 3,
          "text": "Psoriatric arthritis"
        },
        {
          "id": 4,
          "text": "Calcium pyrophosphate dihydrate crystal deposition (CPPD)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pegloticase</strong> is used in the treatment of <strong>chronic gout.</strong></p>\n<div class=\"page\" title=\"Page 711\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pegloticase is a <strong>pegylated uricase</strong> (urate oxidase). It catalyzes the enzymatic oxidation of <strong>uric acid into allantoin</strong>, which is a more soluble and inactive metabolite.</p>\n<p>It is used in the treatment of <strong>severe</strong>,<strong>refractory chronic gout</strong> or in cases where other urate-lowering therapies are contraindicated.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0608",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an inhibitor of RNA synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "5-Fluorouracil"
        },
        {
          "id": 2,
          "text": "Rifampicin"
        },
        {
          "id": 3,
          "text": "Nitrofurantoin"
        },
        {
          "id": 4,
          "text": "Novobiocin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rifampicin </strong>is an inhibitor of RNA synthesis. It&nbsp;binds to the<strong> beta subunit of DNA dependent RNA-polymerase (rpoB) </strong>to form a stable drug-enzyme complex. The binding suppresses the chain formation in RNA synthesis.</p>\n<p>Option A: 5-Fluorouracil inhibits thymidylate synthesis.</p>\n<p>Option C: Nitrofurantoin produces highly reactive intermediates that cause DNA damage</p>\n<p>Option D: Novobiocin is a potent inhibitor of bacterial DNA gyrase.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0783",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following fluoroquinolone is not given in liver disease?",
      "choices": [
        {
          "id": 1,
          "text": "Ofloxacin"
        },
        {
          "id": 2,
          "text": "Levofloxacin"
        },
        {
          "id": 3,
          "text": "Pefloxacin"
        },
        {
          "id": 4,
          "text": "Lomefloxacin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Pefloxacin</strong> is mainly <strong>metabolized in the liver</strong> and hence avoided in patients with liver disease.&nbsp;</p>\n<p>Quinolones with primarily hepatic metabolism include moxifloxacin, pefloxacin, and trovafloxacin (withdrawn from the market due to hepatotoxicity).</p>\n<p>Quinolones primarily excreted by the kidneys include ciprofloxacin, levofloxacin, norfloxacin, lomefloxacin, and ofloxacin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0614",
      "difficulty": "medium"
    },
    {
      "text": "Theophylline causes diuresis by:",
      "choices": [
        {
          "id": 1,
          "text": "Adenosine antagonism"
        },
        {
          "id": 2,
          "text": "PDE 4 inhibition"
        },
        {
          "id": 3,
          "text": "Beta 2 agonism"
        },
        {
          "id": 4,
          "text": "PDE 3 inhibition"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The diuretic effect of theophylline is due to <strong>blockade of adenosine (A1) receptors.</strong></p>\n<p>Theophylline is a methylxanthine drug that acts by:</p>\n<ul>\n<li><strong>Inhibition of phosphodiesterase enzyme</strong> (PDE)<strong>.&nbsp;PDE3</strong> inhibition causes relaxation of bronchial smooth muscle and <strong>PDE4</strong> inhibition causes inhibition of the release of cytokines and chemokines which further leads to a decrease in immune cell migration and activation.</li>\n<li><strong>Blockade of adenosine receptors,&nbsp;</strong>which<strong> inhibits bronchoconstriction.</strong> However,<strong> blockade of A1 receptors</strong> in the glomerular afferent arteriole and PCT causes <strong>diuresis</strong>.</li>\n<li><strong>Activating enzyme histone deacetylase-2</strong>, which is responsible for its anti-inflammatory action</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0610",
      "difficulty": "medium"
    },
    {
      "text": "The graph below shows the relationship between the log(dose) and the response of three drugs, A, B, and C. Which of these drugs has the highest potency?",
      "choices": [
        {
          "id": 1,
          "text": "A"
        },
        {
          "id": 2,
          "text": "B"
        },
        {
          "id": 3,
          "text": "Both A and B"
        },
        {
          "id": 4,
          "text": "C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Drug A</strong> has the highest potency.</p>\n<p><strong>Potency:</strong></p>\n<ul>\n<li>It is defined as the <strong>amount </strong>of drug needed to <strong>produce</strong> a<strong> given response.&nbsp;</strong>A&nbsp;<strong>highly potent drug</strong>&nbsp;evokes a given&nbsp;<strong>response </strong>at<strong> low concentrations</strong>&nbsp;and vice-versa.</li>\n<li>The more the curve is on the<strong> left </strong>in a dose-response curve (DRC)<strong>, </strong>the <strong>greater </strong>is its<strong> potency.&nbsp;</strong></li>\n<li>Thus, in the above image, the potency is Drug A &gt;Drug B&gt; Drug C.</li>\n</ul>\n<p><strong>Efficacy:</strong></p>\n<ul>\n<li>It is defined as the<strong> maximum effect</strong> produced by the drug. It reflects the capacity of the drug to activate a receptor and produce the response.</li>\n<li>In the log dose-response curve, the <strong>perpendicular height</strong> represents the drug efficacy.</li>\n<li>Thus, in the above image, the efficacy is Drug A = Drug B &gt; Drug C.</li>\n<li>Drugs having a similar pharmacological effect can have different efficacies e.g furosemide and metolazone are both diuretics but furosemide has greater efficacy than metolazone.&nbsp;</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b45dbf4ee48b4afaac794cf75bab570a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0607",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented with biliary colic. The intern has administered an analgesic, following which the pain got aggravated. Which of the following could be responsible for the aggravation of the patient's symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Morphine"
        },
        {
          "id": 2,
          "text": "Diclofenac"
        },
        {
          "id": 3,
          "text": "Nefopam"
        },
        {
          "id": 4,
          "text": "Etoricoxib"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Morphine </strong>is the analgesic which could be responsible for the aggravation of the patient's symptoms.</p>\n<p>It&nbsp;causes<strong> constriction of </strong>the <strong>sphincter of Oddi</strong>&nbsp;causing an increase in fluid pressure in the common bile duct and gall bladder.</p>\n<p><strong>Note</strong>: Pethidine causes lesser spasm of the sphincter of Oddi and can be used in biliary colic.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0615",
      "difficulty": "easy"
    },
    {
      "text": "A  patient with gout develops hypertension.  The uric acid level was found to be elevated. Which of the following is not administered?",
      "choices": [
        {
          "id": 1,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 2,
          "text": "Atenolol"
        },
        {
          "id": 3,
          "text": "Enalapril"
        },
        {
          "id": 4,
          "text": "Prazosin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Hydrochlorothiazides</strong> are not given to this patient.</p>\n<p>Gout is a metabolic disease associated with hyperuricemia.Thiazides&nbsp;increase direct urate reabsorption in the proximal renal tubules and are associated with elevated serum uric acid levels and may precipitate gout. Hence, hydrochlorothiazides are not used to treat hypertension in gout patients.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Drugs precipitating Gout</h3><p>Drugs that precipitate gout are-</p>\n<p><strong>C</strong>yclosporine or cancer drugs<br /><strong>A</strong>spirin (low dose)<br /><strong>N</strong>iacin<br /><strong>T</strong>hiazide<br /><strong>L</strong>asix (furosemide)<br /><strong>E</strong>thambutol<br /><strong>A</strong>lcohol<br /><strong>P</strong>yrazinamide</p>\n<p>Mnemonic for drugs precipitating gout is '<strong>CANT LEAP</strong>'</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0780",
      "difficulty": "easy"
    },
    {
      "text": "Voriconazole is not effective against which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Candida albicans"
        },
        {
          "id": 2,
          "text": "Mucormycosis"
        },
        {
          "id": 3,
          "text": "Candida tropicalis"
        },
        {
          "id": 4,
          "text": "Aspergillosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Voriconazole is not effective against <strong>mucormycosis</strong>.</p>\n<p><strong>Mucormycosis</strong> is treated by <strong>amphotericin B</strong>. Posaconazole can also be used. However, other azoles are not effective against this fungus.</p>\n<p>Voriconazole is the drug of choice for the treatment of aspergillosis. It can also be used for Candida species (including glabrata and krusei), Scedosporium and Fusarium.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3876",
      "difficulty": "medium"
    },
    {
      "text": "A patient who was diagnosed with ADPKD was prescribed tolvaptan. After a few weeks, he presented with dry mouth and increased thirst. What is the likely cause?<div class='question-desc-html'><p>ADPKD- Autosomal dominant polycystic kidney disease</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Increased free water clearance"
        },
        {
          "id": 2,
          "text": "V2 receptor agonism"
        },
        {
          "id": 3,
          "text": "Increased renal cAMP levels"
        },
        {
          "id": 4,
          "text": "Increase in urine osmolality"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tolvaptan</strong> causes <strong>increased free water</strong> <strong>clearance</strong>, which causes <strong>dehydration</strong>. Hence, the patient may present with dry mouth and increased thirst.</p>\n<p>Tolvaptan is a vasopressin <strong>V2 receptor antagonist. </strong>Decreased binding of vasopressin to the V2 receptor in the kidney <strong>lowers the adenyl cyclase activity</strong> leading to decreased intracellular cAMP. <strong>Decreased cAMP</strong> concentrations <strong>prevent</strong> the fusion of<strong> aquaporin 2</strong> containing vesicles with the plasma membrane, leading to an increase in urinary water excretion (free water clearance), and a decrease in urine osmolality.</p>\n<p>The common <strong>side effects of tolvaptan</strong> include:</p>\n<ul>\n<li>dehydration</li>\n<li>hypernatremia</li>\n<li>hypovolemia</li>\n<li>liver injury</li>\n</ul>\n<p>Tolvaptan is used to <strong>delay disease progression</strong> in patients with <strong>ADPKD</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7338",
      "difficulty": "medium"
    }
  ]
}